114 related articles for article (PubMed ID: 11093935)
1. Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers.
Dong Z; Wang X; Evers BM
Am J Physiol Gastrointest Liver Physiol; 2000 Dec; 279(6):G1139-47. PubMed ID: 11093935
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation contributes to expression of the human neurotensin/neuromedin N gene.
Dong Z; Wang X; Zhao Q; Townsend CM; Evers BM
Am J Physiol; 1998 Mar; 274(3):G535-43. PubMed ID: 9530155
[TBL] [Abstract][Full Text] [Related]
3. Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line.
Evers BM; Wang X; Zhou Z; Townsend CM; McNeil GP; Dobner PR
Mol Cell Biol; 1995 Jul; 15(7):3870-81. PubMed ID: 7791794
[TBL] [Abstract][Full Text] [Related]
4. Src-mediated activation of the human neurotensin/neuromedin N promoter.
Banker NA; Hellmich MR; Kim HJ; Townsend CM; Evers BM
Surgery; 1997 Aug; 122(2):180-5; discussion 185-6. PubMed ID: 9288121
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
6. Site-specific methylation of the promoter alters deoxyribonucleic acid-protein interactions and prevents follicle-stimulating hormone receptor gene transcription.
Griswold MD; Kim JS
Biol Reprod; 2001 Feb; 64(2):602-10. PubMed ID: 11159363
[TBL] [Abstract][Full Text] [Related]
7. Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N gene.
Wang X; Gulhati P; Li J; Dobner PR; Weiss H; Townsend CM; Evers BM
J Biol Chem; 2011 Jan; 286(1):542-54. PubMed ID: 21030593
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction mechanisms in neurotensin-mediated cellular regulation.
Ehlers RA; Bonnor RM; Wang X; Hellmich MR; Evers BM
Surgery; 1998 Aug; 124(2):239-46; discussion 246-7. PubMed ID: 9706144
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells.
McGough JM; Yang D; Huang S; Georgi D; Hewitt SM; Röcken C; Tänzer M; Ebert MP; Liu K
Mol Cancer Res; 2008 Dec; 6(12):1841-51. PubMed ID: 19074829
[TBL] [Abstract][Full Text] [Related]
10. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
Singal R; van Wert J; Bashambu M
Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin expression and release in human colon cancers.
Evers BM; Ishizuka J; Chung DH; Townsend CM; Thompson JC
Ann Surg; 1992 Oct; 216(4):423-30; discussion 430-1. PubMed ID: 1329682
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of glutaminase 2 in human liver and colon cancers.
Zhang J; Wang C; Chen M; Cao J; Zhong Y; Chen L; Shen HM; Xia D
BMC Cancer; 2013 Dec; 13():601. PubMed ID: 24330717
[TBL] [Abstract][Full Text] [Related]
13. Fetal and neoplastic expression of the neurotensin gene in the human colon.
Evers BM; Zhou Z; Dohlen V; Rajaraman S; Thompson JC; Townsend CM
Ann Surg; 1996 May; 223(5):464-70; discussion 470-1. PubMed ID: 8651737
[TBL] [Abstract][Full Text] [Related]
14. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
[TBL] [Abstract][Full Text] [Related]
15. CpG island methylation status in the EpCAM promoter region and gene expression.
Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y
Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402
[TBL] [Abstract][Full Text] [Related]
16. Methylation adjacent to negatively regulating AP-1 site reactivates TrkA gene expression during cancer progression.
Fujimoto M; Kitazawa R; Maeda S; Kitazawa S
Oncogene; 2005 Jul; 24(32):5108-18. PubMed ID: 15870692
[TBL] [Abstract][Full Text] [Related]
17. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
18. Pro-neurotensin/neuromedin N expression and processing in human colon cancer cell lines.
Rovère C; Barbero P; Maoret JJ; Laburthe M; Kitabgi P
Biochem Biophys Res Commun; 1998 May; 246(1):155-9. PubMed ID: 9600085
[TBL] [Abstract][Full Text] [Related]
19. c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum.
Merchant KM
Mol Cell Neurosci; 1994 Aug; 5(4):336-44. PubMed ID: 7804603
[TBL] [Abstract][Full Text] [Related]
20. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
